A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies

This study has been completed.
Sponsor:
Information provided by:
CASI Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT00506402
First received: July 24, 2007
Last updated: May 4, 2009
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2009
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)